Hepatorenal syndrome, pharmacological therapy, and liver transplantation
✍ Scribed by Pere Ginès
- Book ID
- 102470682
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 66 KB
- Volume
- 17
- Category
- Article
- ISSN
- 1527-6465
- DOI
- 10.1002/lt.22433
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Hepatorenal syndrome (HRS) is a well-recognized complication of end-stage liver disease. Once thought to be a reversible condition with liver transplantation (LT) alone, HRS may directly contribute to the requirement for long-term dialysis posttransplant. As a result, discussion has now focused on w
Important progress has been made recently regarding the pathogenesis and treatment of hepatorenal syndrome (HRS). However, scant information exists about factors predicting outcome in patients with cirrhosis and HRS. Moreover, the prognostic value of the model of end-stage liver disease (MELD) score
Background/Aims: Hepatopulmonary syndrome is defined as a clinical triad including chronic liver disease, abnormal pulmonary gas exchange resulting ultimately in profound arterial hypoxaemia, and evidence of intrapulmonary vascular dilatation. We report five patients with liver cirrhosis diagnosed w